Exenatide Once-Weekly Injection for the Treatment of Type 2 Diabetes in Chinese Patients: Current Perspectives
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s81088
Full Text
Abstract
Available in
Date
August 1, 2015
Authors
Publisher
Informa UK Limited